This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2011 by Universal Biosensors Pty Ltd.
Recruitment status was:  Enrolling by invitation
Sponsor:
Information provided by:
Universal Biosensors Pty Ltd
ClinicalTrials.gov Identifier:
NCT01349712
First received: April 29, 2011
Last updated: May 5, 2011
Last verified: May 2011
April 29, 2011
May 5, 2011
May 2011
November 2011   (Final data collection date for primary outcome measure)
PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device [ Time Frame: Fives days to collect data and up to two weeks to generate correlation graph ]
To determine the correlation of PT/INR values between an experimental and commercial device.
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
Correlation of Feasibility Batches Using Warfarinised Blood
The purpose of this study is to measure prothrombin time (PT) on an experimental device and a commercially available device on persons receiving coumadin (warfarin)treatment.
This study will require participants to have up to 2 finger-punctures taken and sample tested on a strip and meter system for both the experimental and commercially available devices.
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Subjects currently receving coumadin(warfarin) treatment
Blood Coagulation Disorders
Not Provided
Coumadin (warfarin)
Subjects are required to be currently receiving coumadin (warfarin) treatment.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
200
November 2011
November 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Currently taking coumadin (warfarin)
  • Aged 18 years or older
  • Able and willing to provide informed consent
  • Can understand (read and write) English

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01349712
MOB 0158
No
Not Provided
Not Provided
Not Provided
Richard Ward, Assistant Professor, College of Pharmacy Harding University
Universal Biosensors Pty Ltd
Not Provided
Principal Investigator: Richard Ward, Pharm D Harding University
Universal Biosensors Pty Ltd
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP